上海市经信委项目（基于健康大数据的肿瘤智慧精准医疗应用系统研究）；
上海市科委启明星项目（TCR 免疫分析在细胞治疗中的应用探索）；
YE Z L, DING Y M, CHEN Z, LI Z, MA S, XU Z H, CHENG L, WANG X Y, ZHANG X X, DING N, ZHANG Q, QIAN Q J. Detecting and phenotyping of aneuploidcirculating tumor cells in patients with various malignancies [J]. Cancer Biol Ther, 2019, 20(4): 546-51.
Zhu, L N, WU R J,YE Z L, et al. "Identification of two novel TPK1 gene mutations in a Chinese patient with thiamine pyrophosphokinase deficiency undergoing wholeexome sequencing" Journal of Pediatric Endocrinology and Metabolism, 32.3 (2019): 295-300. Retrieved 13 Jun. 2019, from doi:10.1515/jpem-2018-0363
YE Z L, QIAN Q M, JIN H J, QIAN Q J. Cancer vaccine: learning lessons from immune checkpoint inhibitors [J]. J Cancer, 2018, 9(2): 263-8.
LV S Q, YE Z L, LIU P Y, HUANG Y, LI L F, LIU H, ZHU H L, JIN H J, QIAN Q J. 11R-P53 and GM-CSF Expressing Oncolytic Adenovirus Target Cancer Stem Cellswith Enhanced Synergistic Activity [J]. J Cancer, 2017, 8(2): 199-206.
XU J Y, YE Z L, JIANG D Q, HE J C, DING Y M, LI L F, LV S Q, WANG Y, JIN H J, QIAN Q J. Mesothelin-targeting chimeric antigen receptor-modified T cells bypiggyBac transposon system suppress the growth of bile duct carcinoma [J]. Tumor Biol, 2017, 39(4): 11.
XU J Y, YE Z L, JIANG D Q, HE J C, DING Y M, LI L F, LV S Q, WANG Y, JIN H J, QIAN Q J. Mesothelin-targeting chimeric antigen receptor-modified T cells bypiggyBac transposon system suppress the growth of bile duct carcinoma [J]. Tumor Biol, 2017, 39(4): 11.
XU J Y, YE Z L, JIANG D Q, HE J C, DING Y M, LI L F, LV S Q, WANG Y, JIN H J, QIAN Q J. Mesothelin-targeting chimeric antigen receptor-modified T cells bypiggyBac transposon system suppress the growth of bile duct carcinoma [J]. Tumor Biol, 2017, 39(4): 11.
XU J Y, YE Z L, JIANG D Q, HE J C, DING Y M, LI L F, LV S Q, WANG Y, JIN H J, QIAN Q J. Mesothelin-targeting chimeric antigen receptor-modified T cells bypiggyBac transposon system suppress the growth of bile duct carcinoma [J]. Tumor Biol, 2017, 39(4): 11.
021-59593168*508
